Company profile for Neurobiogen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NeuroBiogen is a pharmaceutical company dedicated to developing innovative treatments for degenerative brain diseases and central nervous system disorders. Their research focuses on creating new medicines to aid patients suffering from these conditions. A key development in their pipeline is KDS2010, a potent, highly selective, and reversible monoamine oxidase-B (MAO-B) inhibitor. Unlike irreversible MAO-B inhibitors, KDS2010 ...
NeuroBiogen is a pharmaceutical company dedicated to developing innovative treatments for degenerative brain diseases and central nervous system disorders. Their research focuses on creating new medicines to aid patients suffering from these conditions. A key development in their pipeline is KDS2010, a potent, highly selective, and reversible monoamine oxidase-B (MAO-B) inhibitor. Unlike irreversible MAO-B inhibitors, KDS2010 aims to overcome limitations associated with long-term treatments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
2F Bangbae building, 9, Myeongdal-ro, Seocho-gu, Seoul
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty